Details

Autor(en) / Beteiligte

• Abhinav, Rajendra Prabhu
• Williams, Joanne
• Livingston, Patricia
• Anjana, Ranjit Mohan
• Mohan, Viswanathan

Titel

Burden of diabetes and oral cancer in India

Ist Teil von

• Journal of diabetes and its complications, 2020-11, Vol.34 (11), p.107670-107670, Article 107670

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2020

Link zum Volltext

Quelle

ScienceDirect Journals (5 years ago - present)

Beschreibungen/Notizen

• Oral cancer and diabetes are highly prevalent among the Indian population and are part of the top four non-communicable diseases responsible for mortality and morbidity. Their numbers are so great that they pose a unique burden to the socioeconomic growth of the country. In recent years, there has been an increase in the number of studies examining the role of diabetes in oral cancer reporting co-existence of diabetes and cancer. There is also growing evidence of a higher risk for developing a number of cancers among individuals with diabetes, including pancreatic, liver, gynecologic, colorectal, oral and breast cancer, and consequently ‘diabetic oncopathy’ is emerging as one of the complications of diabetes. Diabetes may lead to the development of cancer through oxidative damage leading to accumulation of DNA mutations and/or through immune dysfunction, which predisposes to viral infection. Cancer and diabetes may co-occur due to shared risk factors such as increased insulin-like growth factor-1 and obesity, but there is no clear biologic link between the two disorders. This literature review aims to review the evidence showing the current burden of two non-communicable diseases, diabetes and oral cancer and their potential association, with particular reference to India. •Review explores the burden of oral cancer and diabetes and their potential association, with particular reference to India.•Increased evidence available on literature reporting co-existence of oral cancer and type-2 diabetes.•Possible mechanisms linking cancer and diabetes- hyperinsulinemia, insulin/IGF axis, chronic inflammation, hyperglycaemia.•Diabetic oncopathy is emerging as one of the complications of diabetes.